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ABSTRACT
Background Despite recent advances in the 
understanding of the genetic architecture of 
osteoarthritis (OA), only two genetic loci have been 
identiied for OA of the hand, in part explained by the 
complexity of the different hand joints and heterogeneity 
of OA pathology.
Methods We used data from the Rotterdam Study 
(RSI, RSII and RSIII) to create three hand OA phenotypes 
based on clustering patterns of radiographic OA severity 
to increase power in our modest discovery genome- wide 
association studies in the RS (n=8700), and sought 
replication in an independent cohort, the Framingham 
Heart Study (n=1203). We used multiple approaches that 
leverage different levels of information and functional 
data to further investigate the underlying biological 
mechanisms and candidate genes for replicated loci. We 
also attempted to replicate known OA loci at other joint 
sites, including the hips and knees.
Results We found two novel genome- wide signiicant 
loci for OA in the thumb joints. We identiied WNT9A 
as a possible novel causal gene involved in OA 
pathogenesis. Furthermore, several previously identiied 
genetic loci for OA seem to confer risk for OA across 
multiple joints: TGFa, RUNX2, COL27A1, ASTN2, IL11 
and GDF5 loci.
Conclusions We identiied a robust novel genetic locus 
for hand OA on chromosome 1, of which WNT9A is the 
most likely causal gene. In addition, multiple genetic loci 
were identiied to be associated with OA across multiple 
joints. Our study conirms the potential for novel insight 
into the genetic architecture of OA by using biologically 
meaningful stratiied phenotypes.
INTRODUCTION
Osteoarthritis (OA) is a serious destructive joint 
disorder and the third most rapidly rising condition 
associated with disability.1 Despite this, no effective 
treatments that target OA are available. Current 
treatments only manage pain, not the underlying 
mechanisms of disease aetiology. An estimated 
5% of the world population is affected by OA, 
with hand OA as one of its most prevalent forms. 
Given the high prevalence with age and high esti-
mated lifetime risk rates for symptomatic hand OA 
(39.8%), the number of individuals affected will 
only continue to increase.2 3 Hand OA has a high 
clinical burden, involving considerable pain, defor-
mity and impaired function.46 In addition, hand 
joints are non- weight bearing, and therefore may 
reflect the systemic aspects of the disease more than 
knee and/or hip OA, where mechanical loading is 
a dominant risk factor.7 A better understanding of 
hand OA, its causes and pathophysiological mecha-
nisms is therefore urgently needed.
Hand OA is a complex multifactorial disorder. 
It shares risk factors, such as repetitive movements 
Key messages
What is already known about this subject?
 Ź Hand osteoarthritis (OA) is one of the most 
prevalent forms of OA and has a large genetic 
component, yet only two common genetic loci 
have been found.
 Ź Lack of indings may be attributed to the 
modest samples sizes in previous genome- 
wide association studies (GWAS) and the high 
disease heterogeneity, which can negatively 
affect statistical power to robustly identify 
genetic loci.
What does this study add?
 Ź Using three distinct hand OA phenotypes 
(hand, inger, thumb OA), based on clustering 
patterns of radiographic OA severity, we have 
increased the power of our GWAS (n~10 000), 
and robustly identiied a novel genetic locus for 
thumb OA.
 Ź Functional genomic data from OA disease 
relevant tissue identiied a potential causal 
variant, predicted to be located in a gene 
regulatory element, which through chromatin 
looping interacts with the WNT9A promoter to 
inluence WNT9A expression.
How might this impact on clinical practice or 
future developments?
 Ź Our results provide the irst evidence for 
WNT9A, a non- canonical Wnt ligand, in human 
thumb OA.
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and obesity, with OA at other joint sites.8 9 Hand OA also has 
a strong genetic component, with heritability estimates ranging 
from 39% to 84% depending on the hand joint affected.10 11 
Recently, major advances were made in elucidating the genetic 
background of hip and knee OA, using large (n>400 000 indi-
viduals) genome- wide association studies (GWAS).1214 Yet, for 
hand OA only two common genetic loci have been found near 
the MGP and ALDH1A2 genes.15 16 The lack of findings for hand 
OA may be attributed to the modest samples sizes (n<9000 indi-
viduals) in previous GWAS and disease heterogeneity,17 which is 
known to reduce power to robustly detect genetic loci.18
OA in the hand may be present in any joint, but is most prev-
alent in the distal interphalangeal joints (DIP), first carpometa-
carpal (CMC1) and trapezioscaphoid (TS) joints, followed by 
the proximal interphalangeal joints (PIP). OA is least prevalent 
in metacarpophalangeal joints (MCP).19 20 Diverse definitions of 
hand OA have been used including nodal hand OA (interpha-
langeal (IP) joints), thumb base OA (CMC1/TS) and generalised 
hand OA (DIP/PIP/CMC1)19 20 with varying results, suggesting 
that disease aetiology may differ between the joints. Moreover, 
OA affects multiple tissues within the joint including cartilage 
and bone. This further contributes to disease heterogeneity and 
warrants the assessment of hand OA by endophenotypes such 
as joint space narrowing (JSN) and osteophytes (OST) that may 
capture separate biological processes underlying OA pathology. 
The use of endophenotypes, quantifiable biological phenotypes 
intermediate to the genes and the disease, has been success-
fully used in OA for the detection of novel genetic loci16 21 22 
in knee and hip OA, and may provide new insights into hand 
OA. For heterogeneous diseases such as OA, stratification of OA 
phenotypes into different dimensions of disease is one way of 
increasing power in GWAS.18
There are few GWAS of hand OA and none has examined 
hierarchically defined clusters of OA joint presentation in the 
hands or hand OA endophenotypes that may provide new 
insights into hand OA pathogenesis. We therefore set out to 
examine the occurrence of OA across hand joints and conduct a 
GWAS stratified by hand OA patterns23 to identify novel genetic 
loci for hand OA.
METHODS
GWAS, discovery, replication and meta-analysis
We conducted GWAS on radiographic structural phenotypes 
for OA of the hand using data from the Rotterdam Study (RS) 
(n~8700).24 For a detailed description of the RS, subcohorts 
and GWAS methods, see online supplemental text and table 1. 
Briefly, genotypes were imputed to the Haplotype Reference 
Consortium reference panel (V.1.0) using the Michigan Impu-
tation Server.25 We assessed genetic associations in each RS 
sub- cohort using linear regression models adjusted for age, sex 
and the first four genetic principal components. RVtests26 was 
used for the GWAS analyses and results were quality controlled 
using EasyQC.27 Variants with an imputation quality <0.3, 
minor allele frequency <0.05 or effective allele count <5 were 
excluded and genomic control correction was applied to all 
SE and p values. Meta- analysis between the discovery cohorts 
was performed using fixed- effects inverse variance weighting 
with METAL.28 Manhattan plots and QQ plots were generated 
using R and R package qqman.29 Independent variants with a 
p<1×10−6 and a χ2 statistic test of heterogeneity p>1×10−6 
were selected for replication in the Framingham Heart Study 
(FHS) (n=1203).30 For a detailed description of the FHS, see the 
online supplemental text. Summary level data from the discovery 
and replication stage were combined in a joint meta- analysis 
(METAL).28 Variants met criteria for replication if the associa-
tion reached a p<0.05, had the same direction of effect as the 
discovery sample and reached a joint meta- analysis p<5×10−8. 
Replicated variants were also examined for association with clin-
ical OA (ie, hospital diagnosed OA) based on GWAS summary 
statistics from a large- scale OA meta- analysis of data from the 
UK Biobank and Icelandic deCODE populations.14 15 For a 
detailed description of the UK Biobank and deCODE, see the 
online supplemental text. Associations that reached a p value 
<0.01 were considered statistically significant.
Detailed phenotype descriptions
For each participant, all hand joints (16 joints per hand, 32 
joints per individual) were scored for Kellgren and Lawrence 
(KL) grade31 based on hand radiographs. KL grade is a semi- 
quantitative score ranging from 0 to 4, where higher scores indi-
cate more severe disease. Radiographic OA was defined as KL 
grade ≥2 (definite JSN and definite OST). Each joint was also 
scored for individual radiographic features including JSN and 
OST.31 The JSN and OST scores are semi- quantitative scores 
ranging from 0 to 3, where 0=none, 1=possible, 2=definite and 
3=marked.
We conducted hierarchical clustering of KL grade across all 
hand joints to identify patterns of disease occurrence defined 
by location and disease severity (see online supplemental text). 
This yielded three semi- quantitative hand OA phenotypes for 
analysis: (1) hand KLsum=sum of KL grades across all DIP, PIP, 
MCP, IP and CMC1 joints in both hands (15 joints per hand, 
30 joints per individual, hand KLsum score range: 0120), (2) 
finger KLsum=sum of KL grades across all DIP and PIP joints in 
both hands (8 joints per hand, 16 joints per individual, KLsum 
score range: 064) and (3) thumb KLsum=sum of KL grades 
across the CMC1 and TS joint (2 joints per hand, 4 joints per 
individual, KLsum score range: 016). Individuals with a missing 
Table 1 General characteristics of the study population
Cohort RSI RSII RSIII
Hand
  n (OA cases) 4829 (1830) 1791 (688) 2071 (526)
  Female (%) 2773 (0.57) 964 (0.54) 1180 (0.57)
  Age (SD) 67.6 (7.9) 64.6 (7.9) 57.1 (7.0)
  KLsum (aver. (SD)) 8.4 (9.9) 6.9 (4.0) 4.7 (6.5)
  Osteophytes (aver. (SD)) 7.1 (7.8) 6.8 (8.2) 4.6 (6.3)
  JSN (aver. (SD)) 0.84 (2.4) 0.34 (1.3) 0.2 (0.8)
Finger
  n (OA cases) 4839 (1244) 1803 (474) 2072 (298)
  Female (%) 2779 (0.57) 972 (0.54) 1181 (0.57)
  Age (SD) 67.6 (7.9) 64.6 (7.9) 57.1 (7.0)
  KLsum (aver. (SD)) 5.8 (7.4) 4.5 (6.1) 3.0 (4.7)
  Osteophytes (aver. (SD)) 4.7 (5.5) 4.3 (5.8) 2.9 (4.5)
  JSN (aver. (SD)) 0.6 (1.9) 0.25 (1.1) 0.1 (0.7)
Thumb
  n (OA cases) 4882 (916) 1813 (255) 2083 (166)
  Female (%) 2785 (0.57) 972 (0.54) 1184 (0.57)
  Age (SD) 67.6 (7.9) 64.6 (7.9) 57.1 (7.0)
  KLsum (aver. (SD)) 2.1 (3.3) 1.2 (2.3) 0.8 (1.7)
  Osteophytes (aver. (SD)) 1.3 (2.1) 0.93 (1.7) 0.6 (1.3)
  JSN (aver. (SD)) 0.4 (1.0) 0.18 (0.63) 0.1 (0.4)
aver., average; JSN, joint space narrowing; KL, Kellgren- Lawerence; OA, 
osteoarthritis; RS, Rotterdam Study.
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KL grade in one or more hand joints were excluded from the 
analysis of phenotypes that required scoring of the missing 
joint(s). Also, individuals with missing age, sex or genetic prin-
cipal components were excluded from all analyses (table 1).
Post-GWAS analysis
Post- GWAS analysis consisted of multiple bioinformatic and 
functional analyses (online supplemental text). Briefly, all 
GWAS variants were annotated using HaploReg (V.4.1) and 
FUMA.32 33 Intersection of variants with epigenetic markers, 
proteins, transcription factor (TF) motifs and binding and 
chromatin interactions was done using data from ROADMAP, 
ENCODE, HaploReg (V.4.1) and the three- dimensional (3D) 
genome browser.3437 Functional studies included expression 
quantitative trait loci (eQTL) analysis, methylation expression 
quantitative trait loci (meQTL) analysis, ATAC- seq analysis and 
differential gene expression analysis. All functional analyses were 
performed in human articular cartilage. Details are provided in 
the online supplemental text.
RESULTS
Patterns of osteoarthritis severity in joints of the hand
We used hierarchical cluster analysis on the KL grades of all 32 
hand joints of the left hand and right hand to identify clusters 
(figure 1). Tight symmetric clustering between the left and right 
joints was seen, in addition to clustering based on joint group, 
which is in line with previous findings19 38 39 (figure 1A,B). 
Clustering based on individual radiographic features, JSN and 
number of OST produced similar symmetric and joint group clus-
ters (online supplemental figures S1 and 2). We observed consis-
tent clustering of the PIP with the DIP joints and the TS with 
the CMC joints (figure 1, online supplemental figures S1 and 
2). Based on these analyses, we created three semi- quantitative 
hand OA phenotypes: hand KLsum, thumb KLsum and finger 
KLsum (table 1).
Identification of genetic hand osteoarthritis loci
We conducted GWAS on each of the three identified hand OA 
phenotypes in a discovery sample that included RSI, RSII and 
RSIII cohorts (n~8700) (online supplemental table S1). In total, 
we identified seven independent signals with genome- wide 
suggestive association (p<1×10−6), which were taken forward 
for replication in the FHS (n=1203) (figure 2 and table 2). In 
total, four independent signals were genome- wide significant in 
the meta- analysis (p≤5×10−8), of which three were significantly 
replicated (p<0.05) (table 2). Two of these signals were novel 
OA associated loci. The first and most significant novel locus 
was located on chromosome 1 near the ZNF678, WNT3A and 
WNT9A genes, with rs10916199 as the lead single nucleotide 
variant (SNV). This signal is replicated (p<0.05) and genome- 
wide significantly associated with thumb KLsum (beta=−0.31, 
p=2.36×10−13). The second replicated novel locus is located 
on chromosome 11 containing the F2, LRP4 and CREB3L1 
genes, and is associated with thumb KLsum (beta=−0.19, 
p=4.7×10−8). We also identified two known OA associated 
loci. The first locus was located near the MGP gene, with 
rs4767133 as the lead SNV. This locus was previously found to 
be associated with hand KLsum.16 The second known OA locus, 
also located on chromosome 12, is the CCDC91 locus, which 
was also previously found to be associated with hand KLsum, 
although it did not reach genome- wide significance.16 Here, the 
lead variant rs12049916, was genome- wide significantly asso-
ciated with hand KLsum (beta=0.78, p=1.5×10−8) and finger 
KLsum (beta=0.58, p=2.0×10−8), but did not reach nominal 
significance in the replication cohort, though the direction of 
effect was the same between discovery and replication cohorts 
(table 2).
To examine if replicated loci were also associated with clin-
ically defined OA, we looked up findings in GWAS summary 
statistics from a recent large- scale OA meta- analysis that included 
the UK Biobank and deCODE populations14 15 (table 3). Of the 
novel signals, only rs10916199 (thumb KLsum) was significantly 
associated with its matching clinical OA phenotype (thumb OA: 
OR=0.9, 95% CI=0.86 to 0.95, p=5.7×10−5). Of the known 
signals, rs4764133 was significantly associated with multiple 
clinical OA phenotypes: thumb OA (OR=1.07, 95% CI=1.03 
to 1.12, p=6.3×10−4), finger OA (OR=1.12, 95% CI=1.07 
to 1.17, p=5.7×10−7), hand OA (OR=1.09, 95% CI=1.04 to 
1.13, p=6.7×10−5) and nominal significantly with knee OA 
(OR=0.99, 95% CI=0.96 to 1.00, p=1.8×10−2) (table 3). In 
addition, we also performed a sensitivity analysis in our discovery 
cohorts to see if the association of rs10916199 with thumb 
Figure 1 Tree- dendrogram and multidimensional scaling (MDS) plot of KL scores in the joints of the hand. (A) Tree- dendogram of complete 
hierarchical clustering of Euclidean distance matrix of KL scores of all hand joints left (L) and right (R). (B) MDS plot of KL scores for all hand joints 
left (L) and right (R). Data consisted of all RSI, RSII and RSIII (n=8691) participants of whom radiographic X- rays of the hands were made. Selected 
phenotypes are depicted by the different (dashed) lines. TS, trapezioscaphoid joints; CMC, carpometacarpal joints; DIP, distal interphalangeal joints; 
IP, interphalangeal joints; KL, Kellgren- Lawrence OA severity score; L/R, left or right joint; MCP, metacarpophalangeal joints; OA, osteoarthritis; PIP, 
proximal interphalangeal joints; IP, interphalangeal joints; number denotes which joint, ie, PIP2- L, the second PIP joint at the left hand. See online 
supplemental igures 2 and 3 for tree dendrogram and MDS plots for joint space narrowing and osteophytosis scores.
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KLsum was driven by body mass index (BMI. After additional 
adjustment for BMI, rs10916199 remained strongly associated 
with thumb KLsum (beta=−0.37, SE=0.05, p=5.8×10−13).
WNT9A as potential causal gene for thumb OA
We examined the rs10916199 locus in more detail given the 
strong and consistent association with thumb OA and thumb 
KLsum. Different levels of information were leveraged for all 
genes within 1 Mb surrounding rs10916199 in order to prior-
itise a putative causal gene (figure 3 and online supplemental 
text). First, we meta- analysed two human osteoarthritic carti-
lage expression quantitative trait loci (eQTL) datasets (n=116, 
hip/knee joints, online supplemental table S1)40 41 and found no 
significant effect of rs10916199 on gene expression in these data-
sets. Next, there were significant methylation quantitative trait 
loci (meQTL) associated with rs10916109 and two CpG sites in 
human osteoarthritic cartilage (knee/hip joints): CpG09796739 
(beta=0.39, FDR p=8.3×10−7) and CpG11520395 (beta=0.21, 
FDR p=5.5×10−3) (figure 3E, zone 2). These methylation sites 
are located in a region flanking an active transcriptional start site 
in primary osteoblasts and chondrogenic cells (figure 3B).
To further assess co- localisation of the identified genetic loci 
with regulatory function during cartilage differentiation, as many 
OA loci haven been linked to skeletal development,42 we inter-
sected the GWAS signals in the locus with accessible chromatin 
regions (ATAC- seq peaks) in rare human fetal cartilage acquired 
Figure 2 Combined Manhattan plot of genome- wide association studies (GWAS) discovery results of all radiographic hand OA structural 
phenotypes. Thumb=thumb KLsum score, inger=inger KLsum score and hand=hand KLsum score. GWAS discovery consists of RSI, RSII and RSIII, 
and was adjusted for age, sex and the irst four genetic principle components. The −log
10
 p values, for each of the ~11 million single nucleotide 
polymorphisms (SNPs) analysed (remaining after EASYQC quality control) from the association studies is plotted against their position per 
chromosome. The dotted red horizontal line corresponds to the genome- wide signiicant threshold (p=5×10−8). The dotted grey line corresponds 
to the selection for replication threshold (p=1×10−6). Lead SNP location is represented by [] (intronic), if the SNP is localised intergenic the dashes 
denotes the distance, - ≤10 kb, -- ≤100 kb, ---- ≤1 Mkb, ---- ≥1 Mkb. For plots of the individual GWAS, see online supplemental igures 3–5.
Table 2 Summary of radiographic hand OA structural phenotypes GWAS results
rsID Chr
Pos
(hg19)
Discovery* Replication† Meta- analysis‡
EA NEA EAF Beta SE P value Beta SE P value Beta SE P value Locus§
Thumb KLsum               
  rs10916199 1 227 902 472 A G 0.81 −0.31 0.04 2.1×10−12 −0.27 0.13 3.8×10−2 −0.31 0.04 2.4×10−13 (ZNF678)
  rs2070852 11 46 744 925 C G 0.69 −0.19 0.04 4.5×10−7 −0.22 0.11 3.4×10−2 −0.19 0.04 4.7×10−8 (F2)
  rs621457 11 75 858 695 A G 0.52 −0.18 0.03 2.4×10−7 −0.07 0.11 5.2×10−1 −0.17 0.03 3.3×10−7 UVRAG-[]--WNT11
Finger KLsum               
  rs4764133 12 15 064 363 T C 0.38 0.61 0.09 5.7×10−12 1.38 0.38 2.7×10−4 0.65 0.09 4.8×10−14 MGP—[]-ERP27
  rs12049916 12 28 359 985 G A 0.22 0.57 0.11 7.5×10−8 0.73 0.44 9.9×10−2 0.58 0.10 2.0×10−8 (CCDC91)
  rs1950427 14 25 955 502 T C 0.12 0.66 0.13 6.2×10−7 0.63 0.53 2.4×10−1 0.66 0.13 3.0×0−7 STXBP6 ---[]---NOVA1
  rs1029003 21 40 309 122 A G 0.46 0.43 0.09 9.3×10−7 0.35 0.37 3.4×10−1 0.42 0.09 5.9×10−7 ETS2---[]---PSMG1
Hand KLsum               
  rs4764133 12 15 064 363 T C 0.38 0.75 0.12 3.0×10−10 1.76 0.49 2.9×10−4 0.81 0.12 2.9×10−12 MGP—[]-ERP27
  rs12049916 12 28 359 985 A G 0.77 0.77 0.14 5.3×10−8 0.90 0.56 0.11 0.78 0.14 1.5×10−8 (CCDC91)
*Discovery consists of RSI, RSII, RSIII, samples sizes per phenotype are: thumb KLsum n=8778; inger KLsum n=8714; hand KLsum n=8629.
†Replication cohorts consist of Framingham Heart Study n=1203.
‡Meta- analysis is discovery and replication cohorts using inverse variance weighted meta- analysis using METAL.
§SNP location represented by [], if the SNP is localised intergenic the dashes denotes the distance, - ≤10 kb, -- ≤100 kb, --- ≤1 Mkb, ----- >1 Mkb.
EA, effect allele; EAF, effect allele frequency; GWAS, genome- wide association studies; NEA, non- effect allele; RS, Rotterdam Study; SNP, single nucleotide polymorphism.
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from proximal and distal long bones from gestational day(E) 
59 of development.43 Two of the SNVs in high LD (r2 ≥0.8, 
figure 3A) with rs10916199 (rs74140304 and rs11588850) 
intersected with accessible chromatin regions across multiple 
human long bone cartilage (figure 3C and 3D). In addition, 
rs74140304 also intersected with an active transcription start 
site in osteoblast and chondrogenic cells (figure 3B).28 Next, 
we examined 3D chromatin conformation in the locus. Since 
no chromatin conformation capture data were available for 
chondrogenic or bone cells, we examined data from human 
mesenchymal stem cells, which are stem cell progenitors for 
chondrocytes and osteoblasts (figure 3G).28 The genomic loca-
tion of rs1158850 (figure 3G, zone 2) appears to come into close 
proximity with the promoter region of WNT9A (figure 3G, zone 
3). In addition, CTCF binding peaks in osteoblasts also intersect 
with the WNT9A promoter region (figure 3F, zone 3), and are 
located near rs11588850 (figure 3F, zone 2).
Next, differential expression analysis between OA lesioned 
and preserved cartilage (hip/knee joints) identified WNT9A as 
the most significant result, with increased expression in OA 
lesioned cartilage (n=21, fold change=2.42, p=9.4×10−8, 
online supplemental table S2). Lastly, we examined whether 
rs11588850 may significantly affect (p<4.0×10−8) the regula-
tory TF binding motifs37 located within the WNT9A promoter.35 
The minor allele (G) of rs11588850 is in high linkage disequi-
librium (r2 >0.8) with the OA risk increasing allele (G) of 
rs10916199, which significantly increases the binding affinity of 
the TF binding motif for RAD21 (G- allele logarithm of odds 
(LOD)=11.2, A- allele LOD=9.8). The RAD21 protein has been 
previously shown to bind to the WNT9A promoter region (online 
supplemental table S3). Thus, our results indicate WNT9A as 
novel OA associated gene, where rs1158850 is a potential regu-
latory variant for WNT9A (figure 3, zones 23).
Additional hand osteoarthritis associated loci
OA is highly heritable and co- occurrence of OA in multiple joint 
sites is well recognised44 . As the hand joints are non- weight 
bearing, causes of OA in these joints may reflect effects of systemic 
risk factors, unlike the hip and knee joint where mechanical 
loading is a dominant risk factor.7 Thus, we examined whether 
other known OA loci may also confer risk for hand OA (figure 4). 
For 29 of the previously reported OA associated SNVs,13 14 
nominally significant associations (p<0.05) were observed for 
one or more hand OA phenotypes. Strong associations were seen 
for known hand OA loci: ALDH1A2- locus (rs3204689), MGP- 
locus (rs4767133) (figure 4A,B) and COG5 (rs3815148),45 an 
SNV identified from a candidate gene study for hand OA. Inter-
estingly, the MGP- loci and ALDH1A2- loci, were only associated 
with finger and/or hand OA phenotypes, but not with thumb 
OA. In contrast, the BCL7A- locus (rs11059094), was only asso-
ciated with thumb OA. Strikingly, several reported knee and hip 
OA loci were also associated with hand OA phenotypes in our 
study (Bonferroni, p<5.8×10−4): RUNX2- locus (rs12154055), 
COL27A1- locus (rs919642), ASTN2- locus (rs13253416), IL11- 
locus (rs4252548), TGFa- locus (rs3771501) and GDF5- locus 
(rs143384) (figure 4B). Since some of these known loci were 
previously found to be associated with knee and/or hip OA, they 
may reflect common mechanisms across all joints in OA.
DISCUSSION
We identified four genome- wide significant loci associated with 
hand OA phenotypes, of which two were novel and specific 
for thumb OA. Integration of multiple lines of data provided T
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cumulative evidence that WNT9A may be a causal gene for 
thumb OA. We first conducted a cluster analysis of hand joints 
to identify less heterogeneous clusters of joints that served as 
the basis of the hand OA phenotypes assessed in this GWAS. 
With this approach of using radiographically defined biolog-
ically relevant OA phenotypes to reduce phenotype heteroge-
neity and increase statistical power, we were able to robustly 
identify known and novel OA loci despite our modest sample 
size (n~9900).18 22 This indicates that assessment of stratified 
phenotypes in OA may be warranted to improve GWAS statis-
tical power and provide novel insight into OA biology.
Using bioinformatic analysis and functional genomics datasets, 
we were able to identify rs1158850 as potential causal variant. 
This SNV is nearby meQTL CpGs and the G allele of this variant 
is predicted to increase RAD21 (RAD21 Cohesin Complex 
Component) binding affinity in a region that has chromatin 
interactions with the WNT9A promoter. RAD21 is a part of 
the cohesion complex, involved in the formation of chromatin 
Figure 3 Schematic overview of part of the rs10916199 locus. (A) LocusZoom plot of rs10916199 locus, the Y- axis depicts the −log
10
 p value 
of the single nucleotide variant (SNV) from the thumb Kellgren- Lawrence (KL)sum genome- wide association studies (GWAS). Colours depict the 
linkage disequilibrium (LD) (r2) between the variant and the LD SNV rs10916199. The X- axis depicts the relative genomic location, depict are the 
protein coding genes at those genomic locations. For this genomic region depicted in igure (B–G) are several epigenetic annotations are plotted. 
(B) Chromatin state, as predicted by the ROADMAP 15- state model on histone modiications, for primary osteoblasts and human mesenchymal stem 
cell- derived chondrocytes. Colours depict chromatin states, legend at bottom of full igure. (C). ATAC- seq peaks from human embryonic cartilage at 
different bone development sites at gestation day(E) 59. (D) Location of the lead SNV, rs10916199 and two putative causal SNVs which co- locative 
with ATAC- seq peaks. (E) Genomic location of rs10916199 meQTL CpG sites. (F) Chip- seq CTCF protein binding peaks from human primary osteoblasts 
from ENCODE. (G) Capture Hi- C chromatin interactions from three- dimensional (3D) genome browser for human mesenchymal stem cells (hMSC) 
and mesoderm. Depicted are the chromatin interactions from the promoters of the queried gene to the genomic location of interaction, this was 
done for the JMJD4/SNAP47 transcription start site (TSS), WNT9A TSS and the WNT3A TSS. For details on methods and underlying data, see online 
supplemental methods.
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loops with CTCF.46 Both RAD21 and CTCF bind to the WNT9A 
promoter region. In line with these findings, WNT9A expression 
was significantly increased in OA lesioned cartilage compared 
with preserved OA cartilage. Combining all results, we postulate 
that rs1158850 is located in a gene regulatory element, increases 
RAD21 binding, and mediated by CTCF, interacts with the 
WNT9A promoter to influence WNT9A expression.
WNT9A (wingless- type MMTV integration site family, member 
9A) previously known as WNT14, is a member of the WNT gene 
family, and has been shown to play a central role in synovial 
joint formation.47 48 Knockout WNT9A mice have severe skeletal 
developmental defects, and are neonatal lethal.49 Expression of 
WNT members by chondrocytes leads to the destruction of the 
cartilage matrix by the upregulation of Wnt/β-catenin signalling. 
Inhibition of WNT members has been suggested as a plausible 
OA therapeutic strategy, with recent success in a murine model 
of OA.50 51 However, this is the first evidence for WNT9A, a 
non- canonical Wnt ligand, in human OA.
In addition, to identifying novel OA loci, we also provide 
evidence for a subset of generalised OA genetic risk loci: 
GDF5 (rs143384), TGFĮ (rs2862851/rs3771501), RUNX2 
(rs12154055), ASTN2 (rs2480930, rs13823416), COL27A1 
(rs919642) and IL11 (rs4252548). These loci should be given 
priority as potential therapeutic targets since genetically 
supported drug targets have been shown to double the success 
rate of therapeutics in clinical development and intervention at 
these target loci may be beneficial regardless of which joint site 
is affected by OA.52
Although collectively our findings implicate WNT9A in 
thumb OA, there are several limitations. First, age is the 
most predominant risk factor for OA, yet the genetic back-
ground may determine the age of onset, rather than the 
lifetime risk for OA. Therefore, future genetic studies may 
benefit from examining the age of onset rather than adjust 
for age.53 Second, our functional findings are based on chon-
drogenic data sourced from several different tissues that did 
not include tissues from the hand joints. However, consis-
tent results were found across the available chondrogenic 
source material from several different origins (primary, cell 
culture, developmental), indicating a more general role for 
the WNT9A locus in chondrocyte functional pathways. Given 
the complex nature of OA susceptibility and the fact that 
pathophysiological causes are not uniform across skeletal 
sites, alterations in WNT9A expression may be seen in other 
Figure 4 Heatmap depicting the effect of osteoarthritis (OA) associated single nucleotide variants (SNVs) in each hand OA phenotype. (A) The found 
associated lead SNVs of the hand OA phenotypes and their beta and p value in the other phenotypes. (B) Depicted are all known OA SNVs which had 
a nominal signiicant effect in at least one stratiied hand OA phenotype. All betas were calculated for the reported effect allele and scaled. Colours 
represent the scaled beta of the effect allele, which is here the minor allele. P values are represented by * in the box. Chr, chromosome; EA, effect 
allele; EAF, effect allele frequency; Gene, reported gene from the GWAs study; KL, Kellgren- Lawrence score; Pos, base pair position on the chromosome 
Hg19.
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joints, but may have a more marked detrimental effect on 
the thumb joints. The lack of genetic association of WNT9A 
variants for knee and hip OA might be due to the pheno-
type definition of these GWAS studies: self- reported OA and 
10th revision of the International Statistical Classification of 
Diseases codes, which do not necessarily correspond or have 
enough statistical power to identify genetic variants associ-
ated to radiographic phenotypes.
In summary, by examining the distribution of radiographic 
OA features in the hand joints, we identified three distinct 
hand OA phenotypes that provided the basis for identifi-
cation of a novel locus for thumb OA despite our modest 
sample size. We identified WNT9A as a plausible causal gene 
for thumb OA, providing new insights into the genetic archi-
tecture of hand OA and a new candidate for OA therapeutic 
development.
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